Sucralfate generic name is Avatropexpa, low platelets after chemotherapy can be treated with Avatropexpa, which is recommended to be used under the supervision of hematologist.
Avastropofol is a thrombopoietin receptor agonist, which can stimulate the proliferation and differentiation of megakaryocytes in bone marrow progenitor cells, thus increasing the production of platelets, and can be used to treat thrombocytopenia associated with chronic liver disease, and is also used in the treatment of thrombocytopenia caused by chemotherapy.
Avatropex should be used under medical supervision. Regularly review the platelet, platelet transfusion is required in case of low platelet emergencies.
Contraindications to Avatropexpa are unclear. Possible adverse reactions after use include arteriovenous thromboembolic events, hyponatremia, upper respiratory tract infections, myalgia arthralgia, and so on. If there is any discomfort during use, immediate medical attention should be sought.